So here is a new article from Laura Holson, the NYTimes writer I had contacted, she had written about Long Haulers in the NYTimes Magazine and I got a hold of her and mentioned Leronlimab for which she thanked me. I also wrote NP to invite her to our trial. I do wonder if she took LL, but it doesn't sound like it.
So the new article doesn't mention leronlimab, but it does mention the NIH spending 1.5 Billion on LH, without us of course.

https://www.nytimes.com/2021/06/21/insider/lo...orter.html